Healthcare Realty Trust Reports Results For the Third Quarter

GlobeNewswire Inc.

October 30, 2024 10:50AM GMT

NASHVILLE, Tenn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the third quarter ended September 30, 2024. Net (loss) income attributable to common stockholders for the three months ended September 30, 2024 was $(93.0) million, or $(0.26) per diluted common share.

KEY THIRD QUARTER HIGHLIGHTS

 

 

 

  • Normalized FFO per share of $0.39, up 1.2% over the prior year period
  • $875 million of proceeds from JV and asset sale transactions through October
  • $447 million of share repurchases year-to-date through October
  • 159,000 square feet, or 49 basis points, of multi-tenant absorption
  • 431,000 square feet of signed new leases in the quarter, the fifth consecutive quarter above 400,000

CAPITAL ALLOCATION

 

 

 

  • The Company closed joint venture and asset sale transactions since the second quarter totaling $478 million bringing proceeds to approximately $875 million through October, which includes the following:
    • $522 million from joint venture transactions
    • $353 million from asset sales
  • The Company has additional transactions under contract and letters of intent that are expected to increase proceeds to approximately $1.1 billion for the year.
  • Through October, the Company has repurchased 27.1 million shares totaling $446.8 million at an average price of $16.48 per share.

MULTI-TENANT OCCUPANCY AND ABSORPTION

  • Multi-tenant sequential occupancy gains continue to track towards full year 2024 expectations provided in the February 2024 Investor Presentation as shown below:

 

 

3Q 2024

YTD 2024

 

Absorption (SF)

158,720

341,473

 

Change in occupancy (bps)

+ 49

+ 106

  • The multi-tenant portfolio occupancy rate was 86.5% and the leased percentage was 87.8% at September 30.
  • Multi-tenant occupancy has increased by 164 basis points over the trailing-twelve-month period. For the Legacy HTA properties, multi-tenant occupancy has increased by 230 basis points for the same period.
  • An updated multi-tenant occupancy and NOI bridge can be found on page 5 of the Key Highlights Investor Presentation located on the Company's website.

LEASING

  • Portfolio leasing activity that commenced in the third quarter totaled 1,641,000 square feet related to 455 leases:
    • 1,054,000 square feet of renewals
    • 587,000 square feet of new and expansion lease commencements
  • The Company signed new leases totaling 431,000 square feet in the quarter, the fifth consecutive quarter above 400,000.

SAME STORE

 

 

 

  • Same Store cash NOI for the third quarter increased 3.1% over the same quarter in the prior year.
  • Tenant retention for the third quarter was 80.5%.
  • Operating expenses decreased 1.5% over the same quarter in the prior year.
  • Third quarter predictive growth measures in the Same Store portfolio include:
    • Average in-place rent increases of 2.8%.
    • Future annual contractual increases of 3.1% for leases commencing in the quarter.
    • Weighted average MOB cash leasing spreads of 3.9% on 847,000 square feet renewed:
      • 7% (<0% spread)
      • 7% (0-3%)
      • 58% (3-4%)
      • 28% (>4%)

BALANCE SHEET

 

 

 

 

  • As of September 30, 2024, net debt to adjusted EBITDA was 6.7 times. Net debt to adjusted EBITDA is expected to be 6.5 times at the end of the year.
  • In October, the Company repaid the remaining $100 million outstanding of Unsecured Term Loan maturing July 2025.
  • As of September 30, 2024, the Company had approximately $1.3 billion of availability under its credit facility.

DIVIDEND

 

 

 

 

  • A dividend of $0.31 per share was paid in August 2024. A dividend of $0.31 per share will be paid on November 27, 2024 to stockholders and OP unitholders of record on November 12, 2024.

GUIDANCE

 

 

 

 

  • The Company's 2024 per share guidance ranges are as follows:

 

 

 

 

EXPECTED 2024

 

 

ACTUAL

 

PRIOR

 

CURRENT

 

 

3Q 2024

YTD

 

LOW

HIGH

 

LOW

HIGH

 

Earnings per share

$

(0.26

)

$

(1.49

)

 

$

(1.50

)

$

(1.40

)

 

$

(1.60

)

$

(1.59

)

 

NAREIT FFO per share

$

0.21

 

$

0.23

 

 

$

0.77

 

$

0.82

 

 

$

0.58

 

$

0.59

 

 

Normalized FFO per share

$

0.39

 

$

1.16

 

 

$

1.53

 

$

1.58

 

 

$

1.55

 

$

1.56

 

  • The Company's 2024 guidance range includes activities outlined in the Components of Expected FFO on page 29 of the Supplemental Information.

The 2024 annual guidance range reflects the Company's view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, interest rates, and operating and general and administrative expenses. The Company's guidance does not contemplate impacts from gains or losses from
dispositions, potential impairments, or debt extinguishment costs, if any. There can be no assurance that the Company's actual results will not be materially higher or lower than these expectations. If actual results vary from these assumptions, the Company's expectations may change.

AD

EARNINGS CALL

 

 

 

 

  • On Wednesday, October 30, 2024, at 11:00 a.m. Eastern Time, Healthcare Realty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends.
  • Simultaneously, a webcast of the conference call will be available to interested parties at https://investors.healthcarerealty.com/corporate-profile/webcasts under the Investor Relations section. A webcast replay will be available following the call at the same address.
  • Live Conference Call Access Details:
    • Domestic Toll-Free Number: +1 404-975-4839 access code 470628;
    • All Other Locations: +1 833-470-1428 access code 470628.
  • Replay Information:
    • Domestic Toll-Free Number: +1 929-458-6194 access code 780754;
    • All Other Locations: +1 866-813-9403 access code 780754.

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes over 650 properties totaling nearly 40 million square feet concentrated in 15 growth markets.

 

Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, without limitation, the following: the Company's expected results may not be achieved; failure to realize the expected benefits of the Merger; significant transaction costs and/or unknown or inestimable liabilities; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; general adverse economic and local real estate conditions; changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in the Company’s proposed market areas; changes in accounting principles generally accepted in the US; policies and guidelines applicable to REITs; the availability of properties to acquire; the availability of financing; pandemics and other health concerns, and the measures intended to prevent their spread and the potential material adverse effect these matters may have on the Company’s business, results of operations, cash flows and financial condition. Additional information concerning the Company and its business, including additional factors that could materially and adversely affect the Company’s financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in the Company’s 2023 Annual Report on Form 10-K and in its other filings with the SEC.

AD

Consolidated Balance Sheets

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

ASSETS

 

 

 

 

 

 

3Q 2024

2Q 2024

1Q 2024

4Q 2023

3Q 2023

Real estate properties

 

 

 

 

 

Land

$

1,195,116

 

$

1,287,532

 

$

1,342,895

 

$

1,343,265

 

$

1,387,821

 

Buildings and improvements

 

10,074,504

 

 

10,436,218

 

 

10,902,835

 

 

10,881,373

 

 

11,004,195

 

Lease intangibles

 

718,343

 

 

764,730

 

 

816,303

 

 

836,302

 

 

890,273

 

Personal property

 

9,246

 

 

12,501

 

 

12,720

 

 

12,718

 

 

12,686

 

Investment in financing receivables, net

 

123,045

 

 

122,413

 

 

122,001

 

 

122,602

 

 

120,975

 

Financing lease right-of-use assets

 

77,728

 

 

81,401

 

 

81,805

 

 

82,209

 

 

82,613

 

Construction in progress

 

125,944

 

 

97,732

 

 

70,651

 

 

60,727

 

 

85,644

 

Land held for development

 

52,408

 

 

59,871

 

 

59,871

 

 

59,871

 

 

59,871

 

Total real estate investments

 

12,376,334

 

 

12,862,398

 

 

13,409,081

 

 

13,399,067

 

 

13,644,078

 

Less accumulated depreciation and amortization

 

(2,478,544

)

 

(2,427,709

)

 

(2,374,047

)

 

(2,226,853

)

 

(2,093,952

)

Total real estate investments, net

 

9,897,790

 

 

10,434,689

 

 

11,035,034

 

 

11,172,214

 

 

11,550,126

 

Cash and cash equivalents

1

 

22,801

 

 

137,773

 

 

26,172

 

 

25,699

 

 

24,668

 

Assets held for sale, net

 

156,218

 

 

34,530

 

 

30,968

 

 

8,834

 

 

57,638

 

Operating lease right-of-use assets

 

259,013

 

 

261,976

 

 

273,949

 

 

275,975

 

 

323,759

 

Investments in unconsolidated joint ventures

 

417,084

 

 

374,841

 

 

309,754

 

 

311,511

 

 

325,453

 

Other assets, net and goodwill

 

491,679

 

 

559,818

 

 

605,047

 

 

842,898

 

 

822,084

 

Total assets

$

11,244,585

 

$

11,803,627

 

$

12,280,924

 

$

12,637,131

 

$

13,103,728

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

3Q 2024

2Q 2024

1Q 2024

4Q 2023

3Q 2023

Liabilities

 

 

 

 

 

Notes and bonds payable

$

4,957,796

 

$

5,148,153

 

$

5,108,279

 

$

4,994,859

 

$

5,227,413

 

Accounts payable and accrued liabilities

 

197,428

 

 

195,884

 

 

163,172

 

 

211,994

 

 

204,947

 

Liabilities of properties held for sale

 

7,919

 

 

1,805

 

 

700

 

 

295

 

 

3,814

 

Operating lease liabilities

 

229,925

 

 

230,601

 

 

229,223

 

 

229,714

 

 

273,319

 

Financing lease liabilities

 

71,887

 

 

75,199

 

 

74,769

 

 

74,503

 

 

74,087

 

Other liabilities

 

180,283

 

 

177,293

 

 

197,763

 

 

202,984

 

 

211,365

 

Total liabilities

 

5,645,238

 

 

5,828,935

 

 

5,773,906

 

 

5,714,349

 

 

5,994,945

 

 

 

 

 

 

 

Redeemable non-controlling interests

 

3,875

 

 

3,875

 

 

3,880

 

 

3,868

 

 

3,195

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

Preferred stock, $0.01 par value; 200,000 shares authorized

 

 

 

 

 

 

 

 

 

 

Common stock, $0.01 par value; 1,000,000 shares authorized

 

3,558

 

 

3,643

 

 

3,815

 

 

3,810

 

 

3,809

 

Additional paid-in capital

 

9,198,004

 

 

9,340,028

 

 

9,609,530

 

 

9,602,592

 

 

9,597,629

 

Accumulated other comprehensive (loss) income

 

(16,963

)

 

6,986

 

 

4,791

 

 

(10,741

)

 

17,079

 

Cumulative net income attributable to common stockholders

 

481,155

 

 

574,178

 

 

717,958

 

 

1,028,794

 

 

1,069,327

 

Cumulative dividends

 

(4,150,328

)

 

(4,037,693

)

 

(3,920,199

)

 

(3,801,793

)

 

(3,684,144

)

Total stockholders' equity

 

5,515,426

 

 

5,887,142

 

 

6,415,895

 

 

6,822,662

 

 

7,003,700

 

Non-controlling interest

 

80,046

 

 

83,675

 

 

87,243

 

 

96,252

 

 

101,888

 

Total Equity

 

5,595,472

 

 

5,970,817

 

 

6,503,138

 

 

6,918,914

 

 

7,105,588

 

Total liabilities and stockholders' equity

$

11,244,585

 

$

11,803,627

 

$

12,280,924

 

$

12,637,131

 

$

13,103,728

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

2Q 2024 cash and cash equivalents includes $96.0 million of proceeds held in a cash escrow account from a portfolio disposition that closed on June 28, 2024 and was received by the Company on July 1, 2024.

 

 

Consolidated Statements of Income

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

 

 

 

 

 

 

 

3Q 2024

2Q 2024

1Q 2024

4Q 2023

3Q 2023

Revenues

 

 

 

 

 

Rental income

1

$

306,499

 

$

308,135

 

$

318,076

 

$

322,076

 

$

333,335

 

Interest income

 

3,904

 

 

3,865

 

 

4,538

 

 

4,422

 

 

4,264

 

Other operating

 

5,020

 

 

4,322

 

 

4,191

 

 

3,943

 

 

4,661

 

 

 

315,423

 

 

316,322

 

 

326,805

 

 

330,441

 

 

342,260

 

Expenses

 

 

 

 

 

Property operating

 

120,232

 

 

117,719

 

 

121,078

 

 

121,362

 

 

131,639

 

General and administrative

 

20,124

 

 

14,002

 

 

14,787

 

 

14,609

 

 

13,396

 

Normalizing items 2

 

(6,861

)

 

 

 

 

 

(1,445

)

 

 

Normalized general and administrative

 

13,263

 

 

14,002

 

 

14,787

 

 

13,164

 

 

13,396

 

Transaction costs

 

719

 

 

431

 

 

395

 

 

301

 

 

769

 

Merger-related costs

 

 

 

 

 

 

 

1,414

 

 

7,450

 

Depreciation and amortization

 

163,226

 

 

173,477

 

 

178,119

 

 

180,049

 

 

182,989

 

 

 

304,301

 

 

305,629

 

 

314,379

 

 

317,735

 

 

336,243

 

Other income (expense)

 

 

 

 

 

Interest expense before merger-related fair value

 

(50,465

)

 

(52,393

)

 

(50,949

)

 

(52,387

)

 

(55,637

)

Merger-related fair value adjustment

 

(10,184

)

 

(10,064

)

 

(10,105

)

 

(10,800

)

 

(10,667

)

Interest expense

 

(60,649

)

 

(62,457

)

 

(61,054

)

 

(63,187

)

 

(66,304

)

Gain on sales of real estate properties and other assets

 

39,310

 

 

38,338

 

 

22

 

 

20,573

 

 

48,811

 

Gain on extinguishment of debt

 

 

 

 

 

 

 

 

 

62

 

Impairment of real estate assets and credit loss reserves

 

(84,394

)

 

(132,118

)

 

(15,937

)

 

(11,403

)

 

(56,873

)

Impairment of goodwill

 

 

 

 

 

(250,530

)

 

 

 

 

Equity income (loss) from unconsolidated joint ventures

 

208

 

 

(146

)

 

(422

)

 

(430

)

 

(456

)

Interest and other (expense) income, net

 

(132

)

 

(248

)

 

275

 

 

65

 

 

139

 

 

 

(105,657

)

 

(156,631

)

 

(327,646

)

 

(54,382

)

 

(74,621

)

Net (loss) income

$

(94,535

)

$

(145,938

)

$

(315,220

)

$

(41,676

)

$

(68,604

)

Net loss (income) attributable to non-controlling interests

 

1,512

 

 

2,158

 

 

4,384

 

 

1,143

 

 

760

 

Net (loss) income attributable to common stockholders

$

(93,023

)

$

(143,780

)

$

(310,836

)

$

(40,533

)

$

(67,844

)

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per common share

$

(0.26

)

$

(0.39

)

$

(0.82

)

$

(0.11

)

$

(0.18

)

Diluted earnings per common share

$

(0.26

)

$

(0.39

)

$

(0.82

)

$

(0.11

)

$

(0.18

)

 

 

 

 

 

 

Weighted average common shares outstanding - basic

 

358,960

 

 

372,477

 

 

379,455

 

 

379,044

 

 

378,925

 

Weighted average common shares outstanding - diluted

3

 

358,960

 

 

372,477

 

 

379,455

 

 

379,044

 

 

378,925

 

1

In 2Q 2024, rental income was reduced by $3.0 million for Steward Health revenue reserves. This consisted of $2.2 million for April and prepetition rent for May as well as $0.8 million for March. In addition, the Company reversed $2.2 million of straight-line rent receivable against rental income.

2

3Q 2024 and 4Q 2023 normalizing items primarily include severance-related costs.

3

Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount. As a result, the outstanding limited partnership units in the Company's operating partnership ("OP"), totaling 3,649,637 units were not included.

 

 

Reconciliation of FFO, Normalized FFO and FAD 1,2,3

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA

 

 

 

 

 

 

 

3Q 2024

2Q 2024

1Q 2024

4Q 2023

3Q 2023

Net loss attributable to common stockholders

$

(93,023

)

$

(143,780

)

$

(310,836

)

$

(40,533

)

$

(67,844

)

Net loss attributable to common stockholders/diluted share3

$

(0.26

)

$

(0.39

)

$

(0.82

)

$

(0.11

)

$

(0.18

)

 

 

 

 

 

 

Gain on sales of real estate assets

 

(39,148

)

 

(33,431

)

 

(22

)

 

(20,573

)

 

(48,811

)

Impairments of real estate assets

 

37,632

 

 

120,917

 

 

15,937

 

 

11,403

 

 

56,873

 

Real estate depreciation and amortization

 

167,821

 

 

177,350

 

 

181,161

 

 

182,272

 

 

185,143

 

Non-controlling loss from operating partnership units

 

(1,372

)

 

(2,077

)

 

(4,278

)

 

(491

)

 

(841

)

Unconsolidated JV depreciation and amortization

 

5,378

 

 

4,818

 

 

4,568

 

 

4,442

 

 

4,421

 

FFO adjustments

$

170,311

 

$

267,577

 

$

197,366

 

$

177,053

 

$

196,785

 

FFO adjustments per common share - diluted

$

0.47

 

$

0.71

 

$

0.51

 

$

0.46

 

$

0.51

 

FFO

$

77,288

 

$

123,797

 

$

(113,470

)

$

136,520

 

$

128,941

 

FFO per common share - diluted4

$

0.21

 

$

0.33

 

$

(0.30

)

$

0.36

 

$

0.34

 

 

 

 

 

 

 

Transaction costs

 

719

 

 

431

 

 

395

 

 

301

 

 

769

 

Merger-related costs

 

 

 

 

 

 

 

1,414

 

 

7,450

 

Lease intangible amortization

 

(10

)

 

129

 

 

175

 

 

261

 

 

213

 

Non-routine legal costs/forfeited earnest money received

 

306

 

 

465

 

 

 

 

(100

)

 

 

Debt financing costs

 

 

 

 

 

 

 

 

 

(62

)

Restructuring and severance-related charges

 

6,861

 

 

 

 

 

 

1,445

 

 

 

Credit losses and gains on other assets, net

5

 

46,600

 

 

8,525

 

 

 

 

 

 

 

Impairment of goodwill

 

 

 

 

 

250,530

 

 

 

 

 

Merger-related fair value adjustment

 

10,184

 

 

10,064

 

 

10,105

 

 

10,800

 

 

10,667

 

Unconsolidated JV normalizing items

6

 

101

 

 

89

 

 

87

 

 

89

 

 

90

 

Normalized FFO adjustments

$

64,761

 

$

19,703

 

$

261,292

 

$

14,210

 

$

19,127

 

Normalized FFO adjustments per common share - diluted

$

0.18

 

$

0.05

 

$

0.68

 

$

0.04

 

$

0.05

 

Normalized FFO

$

142,049

 

$

143,500

 

$

147,822

 

$

150,730

 

$

148,068

 

Normalized FFO per common share - diluted

$

0.39

 

$

0.38

 

$

0.39

 

$

0.39

 

$

0.39

 

 

 

 

 

 

 

Non-real estate depreciation and amortization

 

276

 

 

313

 

 

485

 

 

685

 

 

475

 

Non-cash interest amortization, net

7

 

1,319

 

 

1,267

 

 

1,277

 

 

1,265

 

 

1,402

 

Rent reserves, net

8

 

(27

)

 

1,261

 

 

(151

)

 

1,404

 

 

442

 

Straight-line rent income, net

 

(5,771

)

 

(6,799

)

 

(7,633

)

 

(7,872

)

 

(8,470

)

Stock-based compensation

 

4,064

 

 

3,383

 

 

3,562

 

 

3,566

 

 

2,556

 

Unconsolidated JV non-cash items

9

 

(376

)

 

(148

)

 

(122

)

 

(206

)

 

(231

)

Normalized FFO adjusted for non-cash items

 

141,534

 

 

142,777

 

 

145,240

 

 

149,572

 

 

144,242

 

2nd generation TI

 

(16,951

)

 

(12,287

)

 

(20,204

)

 

(18,715

)

 

(21,248

)

Leasing commissions paid

 

(10,266

)

 

(10,012

)

 

(15,215

)

 

(14,978

)

 

(8,907

)

Building capital

 

(7,389

)

 

(12,835

)

 

(5,363

)

 

(17,393

)

 

(14,354

)

Total maintenance capex

 

(34,606

)

 

(35,134

)

 

(40,782

)

 

(51,086

)

 

(44,509

)

FAD

$

106,928

 

$

107,643

 

$

104,458

 

$

98,486

 

$

99,733

 

Quarterly/dividends and OP distributions

$

113,770

 

$

118,627

 

$

119,541

 

$

118,897

 

$

119,456

 

FFO wtd avg common shares outstanding - diluted10

 

363,370

 

 

376,556

 

 

383,413

 

 

383,326

 

 

383,428

 

1

Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by NAREIT. NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.”

2

FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.

3

Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount.

4

For 1Q 2024, basic weighted average common shares outstanding was the denominator used in the per share calculation.

5

3Q 2024 includes $46.8 million of credit loss reserves and $0.2 million gain on other assets. 2Q 2024 includes $11.2 million of credit loss reserves and $2.2 million write-off of prior period Steward Health straight-line rent, offset by $4.9 million gain on other assets.

6

Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.

7

Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.

8

2Q 2024 includes $0.8 million related to the Steward Health revenue reserve for March.

9

Includes the Company's proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.

10

The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding of 760,552 for the three months ended September 30, 2024. Also includes the diluted impact of 3,649,637 OP units outstanding.

 

 

Reconciliation of Non-GAAP Measures

DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED

 

Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, and funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.

The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.

AD

FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.

AD

Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.

AD

Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income and less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, tenant improvement amortization and leasing commission amortization. Cash NOI is historical and not necessarily indicative of future results.

Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.

The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.

Any recently acquired property will be included in the same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the same store pool eight full quarters after substantial completion.

Ron Hubbard
Vice President, Investor Relations
P: 615.269.8290

AD